Deutsche Bank downgraded Flywire (FLYW) to Hold from Buy with a price target of $16, down from $26. The company missed on Q4 revenue less ...
Hosted on MSN26d
Deutsche Bank Q4 profit drops, hurt by litigation, other itemsDeutsche Bank (NYSE:DB) stock slid 1.7% in Thursday morning trading after the German lender turned in Q4 profit that was heavily impacted by one-time items, chiefly litigation expenses.
Deutsche Bank Aktiengesellschaft's Q4 results showed an 8.6% revenue increase but a 17% drop in pre-tax profit due to higher non-operating costs. The bank's net interest income and margin grew ...
Deutsche Bank DB reported fourth-quarter 2024 earnings attributable to its shareholders of €106 million ($113 million), down 92% year over year. The Germany-based lender reported a profit before ...
Deutsche Bank reported solid Q4 results with €7.2 billion in revenue, driven by a 30% YoY jump in the investment bank. The 2025 outlook is mixed, with expected mid-single-digit revenue growth ...
Sumit Roy; President, Chief Executive Officer, Director; Realty Income Corp Jonathan Pong; Chief Financial Officer, Executive Vice President, Treasurer; Realty Income Corp Farrell Granath; Analyst; ...
Deutsche Bank has today posted a bigger than expected drop in fourth quarter and 2024 full-year profit as legal provisions and restructuring costs eroded revenue gains at its global investment ...
Deutsche Bank's shares experienced a significant decline on Thursday, dropping 3.2% to €18.90 in XETRA trading following disappointing fourth-quarter results. The financial institution's ...
Net profit attributable to Deutsche Bank shareholders for Q4 2024 came up to €106 million, plummeting 92% from the corresponding period in 2023. This was also significantly below the €282.39m ...
Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results